Keyphrases
Interleukin-17 (IL-17)
100%
Malignant Glioma
100%
T Helper 17 (Th17)
100%
Glioma
50%
Stem Cells
30%
Glioma Progression
20%
Clinical Intervention
10%
Phosphorylation
10%
Functional Significance
10%
Tumor
10%
Glioma Cells
10%
Matrigel
10%
Tumor Inflammation
10%
Immunohistochemistry
10%
Catenin
10%
NF-B
10%
Glycogen Synthase Kinase 3 (GSK3)
10%
Multicolor Flow Cytometry
10%
Myeloid Cells
10%
Tumor Subtype
10%
Tumor Progression
10%
Antitumor Activity
10%
In Vivo Analysis
10%
TGF-1
10%
3D in Vitro Culture
10%
T Cell Subtypes
10%
Cell Signaling Assays
10%
Extracranial Tumors
10%
Pro-tumor
10%
Tumor-infiltrating Immune Cells
10%
Experimental Strategies
10%
CD11b+
10%
Immune-suppressive
10%
Glioma Tissue
10%
Medicine and Dentistry
Ganglioglioma
100%
Glioblastoma
100%
Interleukin 17
100%
Neoplasm
50%
Receptor
37%
Th17 Cell
37%
Prevalence
12%
In Vitro
12%
T Cell
12%
Cytokine
12%
Immunocompetent Cell
12%
Antineoplastic Activity
12%
Clinical Intervention
12%
Matrigel
12%
Immunohistochemistry
12%
Flow Cytometry
12%
Catenin
12%
Ex Vivo
12%
Myeloid Cell
12%
Tumor Progression
12%
Glioma Cell
12%
Cell Signaling Assay
12%
Glycogen Synthase Kinase
12%
Neuroscience
Interleukin 17
100%
Eicosanoid Receptor
75%
Cell Signaling
25%
STAT3
25%
Clinical Intervention
25%
Myeloid
25%
Flow Cytometry
25%
In Vitro
25%
Catenin
25%
Matrigel
25%
GSK-3
25%
T Cell
25%
Immunohistochemistry
25%
Immunology and Microbiology
Interleukin 17
100%
Th17 Cell
75%
Immunocompetent Cell
25%
Myeloid
25%
Prevalence
25%
Antineoplastic Activity
25%
Glioma Cell
25%
Cytokine
25%
Signal Transduction
25%
T Cell
25%
STAT3
25%
Catenin
25%